Cited by

• Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.

  Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, van Vollenhoven R, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcón GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT; Systemic Lupus International Collaborating Clinics. Hanly JG, et al. Arthritis Rheum. 2008 Mar;58(3):843-53. doi: 10.1002/art.23218. Arthritis Rheum. 2008. PMID: 18311802 Free PMC article.
• Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

  Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farías P, Barros LF, Torrealba F, Massardo L, Jacobelli S, González A. Matus S, et al. J Exp Med. 2007 Dec 24;204(13):3221-34. doi: 10.1084/jem.20071285. Epub 2007 Dec 3. J Exp Med. 2007. PMID: 18056288 Free PMC article.
• Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.

  Shinjo SK, Bonfá E. Shinjo SK, et al. Clin Rheumatol. 2011 Feb;30(2):173-7. doi: 10.1007/s10067-010-1432-4. Epub 2010 Mar 28. Clin Rheumatol. 2011. PMID: 20349257
• Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.

  Tay SH, Mak A. Tay SH, et al. Int J Mol Sci. 2015 May 6;16(5):10281-300. doi: 10.3390/ijms160510281. Int J Mol Sci. 2015. PMID: 25955648 Free PMC article. Review.
• Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy.

  Gono T, Kawaguchi Y, Yamanaka H. Gono T, et al. BMC Med. 2013 Apr 4;11:91. doi: 10.1186/1741-7015-11-91. BMC Med. 2013. PMID: 23556481 Free PMC article.